1. Low Replicative Stress Triggers Cell-Type Specific Inheritable Advanced Replication Timing
- Author
-
Elodie Bournique, Lilas Courtot, Chrystelle Maric, Miguel Madrid-Mencía, Jean-Sébastien Hoffmann, Vera Pancaldi, Jean-Charles Cadoret, Laure Guitton-Sert, Valérie Bergoglio, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherches en Cancérologie de Toulouse (CRCT), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre National de la Recherche Scientifique (CNRS), Institut Jacques Monod (IJM (UMR_7592)), Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP), Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), CHU Toulouse [Toulouse]-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Barcelona Supercomputing Center, Basbous, Jihane, Ribeyre, Cyril, Shimizu, Takahiko, Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), Bergoglio, Valérie, and Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
Cell division ,[SDV]Life Sciences [q-bio] ,Epigenesis, Genetic ,chemistry.chemical_compound ,0302 clinical medicine ,DNA Replication Timing ,Gene expression ,Biology (General) ,Spectroscopy ,0303 health sciences ,Chromatin accessibility ,General Medicine ,ADN -- Anàlisi ,Chromatin ,DNA replication stress ,3. Good health ,Computer Science Applications ,Cell biology ,[SDV] Life Sciences [q-bio] ,Histone Code ,Chemistry ,Aphidicolin ,Informàtica::Aplicacions de la informàtica::Bioinformàtica [Àrees temàtiques de la UPC] ,DNA damage ,Heterochromatin ,QH301-705.5 ,Biology ,Models, Biological ,Catalysis ,Article ,Inorganic Chemistry ,03 medical and health sciences ,Stress, Physiological ,Cell Line, Tumor ,Humans ,Physical and Theoretical Chemistry ,Molecular Biology ,QD1-999 ,030304 developmental biology ,Replication timing ,Organic Chemistry ,Cromosomes ,chemistry ,Genetic Loci ,chromatin accessibility ,DNA replication timing ,030217 neurology & neurosurgery - Abstract
DNA replication timing (RT), reflecting the temporal order of origin activation, is known as a robust and conserved cell-type specific process. Upon low replication stress, the slowing of replication forks induces well-documented RT delays associated to genetic instability, but it can also generate RT advances that are still uncharacterized. In order to characterize these advanced initiation events, we monitored the whole genome RT from six independent human cell lines treated with low doses of aphidicolin. We report that RT advances are cell-type-specific and involve large heterochromatin domains. Importantly, we found that some major late to early RT advances can be inherited by the unstressed next-cellular generation, which is a unique process that correlates with enhanced chromatin accessibility, as well as modified replication origin landscape and gene expression in daughter cells. Collectively, this work highlights how low replication stress may impact cellular identity by RT advances events at a subset of chromosomal domains This work was supported by “la Ligue nationale contre le cancer” (LNCC labellisation to JSH and VB and the grants RS16/75-108 and RS17/75-135 to JCC), the “Institut National du Cancer” (INCA, PLBIO2016-10493 to JSH, VB and JCC), the “Centre de Recherches en Cancérologie de Toulouse” to VB, the “Laboratoire d’excellence Toulouse Cancer—TOUCAN” to JSH, the “Groupement des Entreprises Françaises contre le Cancer” (GEFLUC) to JCC, the “IdEx Université de Paris” (ANR-18-IDEX-0001) to JCC, the generous legacy from Ms Suzanne Larzat to JCC, and “la Fondation pour la Recherche Médicale” to LC. MM and VP were funded by INSERM, the “Fondation Toulouse Cancer Santé” and “Pierre Fabre Research Institute” as part of the Chair of Bioinformatics in Oncology of the CRCT.
- Published
- 2021
- Full Text
- View/download PDF